Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma

NCT02393820 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT02393820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Completed
Start date
August 26, 2013
Completion date
October 31, 2019
Enrollment
72 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

salivary gland carcinoma